Loading institutional data...
Loading institutional data...
Insufficient data to determine institutional momentum.
Data as of Q3 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading analysis...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading insider activity...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Ranked against 24 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-09-30.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| QCOM | $184.5B | 13.6× | 19.0× | 4.3× | -2.6% | 53.1% | 31.6% | 44.8% | 29.9% | 1.0× | 1,051 |
| MSI | $87.8B | 41.7× | 28.1× | 7.5× | 8.0% | 51.7% | 18.4% | 89.4% | 18.6% | 2.3× | 450 |
| LITE | $54.1B | — | 82.2× | 17.9× | 83.2% | 41.7% | -230% | -149% | -110% | -0.6× | 380 |
| UI | $40.5B | 42.3× | 33.2× | 12.4× | 27.2% | 46.2% | 29.3% | 66.7% | 66.7% | -0.4× | 71 |
| CIEN | $39.8B | 330.1× | 133.3× | 8.3× | 18.8% | 42.0% | 2.6% | 4.5% | 2.9% | 1.5× | 296 |
| FN | $11.7B | 25.1× | 21.4× | 2.5× | 35.7% | 12.0% | 10.2% | 19.3% | 19.3% | -0.7× | 150 |
| ESE | $6.0B | 20.0× | 24.8× | 5.5× | 19.2% | 42.1% | 27.3% | 19.4% | 17.3% | 0.3× | 91 |
| PL | $5.0B | — | — | 16.3× | 25.9% | 56.1% | -80.2% | -131% | -131% | — | 71 |
| ONDS | $3.1B | — | — | 60.2× | 605% | 39.7% | -261% | -30.2% | -30.2% | — | 98 |
| HLIT | $1.1B | — | 43.7× | 3.1× | -26.2% | 48.5% | -12.0% | -11.3% | -8.7% | -0.5× | 48 |
| NSSC | $1.1B | 25.2× | 20.1× | 5.3× | 11.4% | 59.2% | 21.3% | 22.5% | 22.5% | -2.7× | 52 |
| VISN | $863M | 0.4× | 109.2× | 0.5× | 39.7% | 49.5% | — | -227% | 36.5% | — | 48 |
| UMAC | $586M | — | — | 52.3× | 101% | 34.9% | -171% | -11.0% | -11.0% | — | 36 |
| NTGR | $512M | — | — | 0.7× | 3.8% | 38.0% | -2.6% | -3.6% | -3.6% | — | 29 |
| GILT | $431M | 16.4× | 5.6× | 0.9× | 47.9% | 29.5% | 4.6% | 4.1% | 4.1% | -3.5× | 17 |
| CLFD | $402M | — | 46.1× | 2.7× | 19.6% | 33.7% | -5.4% | -3.1% | -3.1% | -2.6× | 19 |
| ADTN | $394M | — | 3.9× | 0.4× | 17.5% | 38.3% | -4.2% | -31.3% | -31.3% | -1.2× | 27 |
| AIOT | $328M | — | 7.2× | 0.7× | 22.4% | 55.5% | -4.6% | -4.3% | -2.7% | 3.0× | 24 |
| TBCH | $292M | 21.2× | 10.3× | 0.9× | -14.2% | 37.3% | 4.9% | 12.2% | 8.6% | 1.2× | 20 |
| BKTI | $232M | 17.9× | 11.8× | 2.7× | 12.5% | 48.8% | 15.7% | 30.3% | 30.3% | -1.3× | 12 |
| AVNW | $224M | 91.3× | 11.0× | 0.5× | 1.2% | 31.5% | 0.6% | 0.9% | 0.7% | 1.1× | 19 |
| CRNT | $218M | — | 11.0× | 0.6× | -14.1% | 33.8% | -0.6% | -1.2% | -1.1% | -1.1× | 11 |
| AUDC | $211M | 29.3× | 9.3× | 0.9× | 1.4% | 65.0% | 3.6% | 5.2% | 5.2% | -2.5× | 4 |
| VUZI | $115M | — | — | 18.3× | 9.1% | -16.9% | -514% | -131% | -131% | — | 14 |
| RSKIA | $101M | 8.9× | 13.3× | 4.1× | 10.3% | 48.1% | 45.8% | 18.0% | 18.0% | -0.7× | — |
Peers = companies sharing ESE's sector (Communications Equipment, NEC) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
What the company returns to shareholders — and whether it's covered by cash.
The dividend is comfortably covered — only 4% of free cash flow, leaving room to grow it and fund buybacks. Last year: $8.3M dividends + $0 buybacks = $8.3M returned on $205.6M FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Modest payoff on reinvested capital. Current ROIC on all capital: 17%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
EOD close · as of 2026-11-13
How a revenue dollar becomes profit — FY2025
Dividends and buybacks are cash paid out, shown here against the same year's profit for scale — not funded from it.
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.10B 100.0% | $919.1M 100.0% | $855.8M 100.0% | $857.5M 100.0% | $715.4M 100.0% | $730.5M 100.0% | $726.0M 100.0% | $771.6M 100.0% | $685.7M 100.0% | $571.5M 100.0% |
| Cost of Revenue | $634.3M 57.9% | $530.6M 57.7% | $502.7M 58.7% | $525.5M 61.3% | $445.0M 62.2% | $458.3M 62.7% | $438.0M 60.3% | $419.7M 54.4% | $436.9M 63.7% | $350.8M 61.4% |
| Research & Development | $23.0M 2.1% | $12.0M 1.3% | $13.0M 1.5% | $12.3M 1.4% | $15.4M 2.2% | $13.3M 1.8% | $12.1M 1.7% | $10.9M 1.4% | $14.0M 2.0% | $12.2M 2.1% |
| Selling, General & Admin | $234.6M 21.4% | $208.2M 22.7% | $203.5M 23.8% | $195.1M 22.8% | $167.5M 23.4% | $159.5M 21.8% | $162.7M 22.4% | $153.1M 19.8% | $148.4M 21.6% | $131.5M 23.0% |
| Total Operating Expenses | $942.5M 86.0% | $788.2M 85.8% | $745.4M 87.1% | $751.1M 87.6% | $634.8M 88.7% | $694.1M 95.0% | $628.2M 86.5% | $602.6M 78.1% | $605.6M 88.3% | $503.0M 88.0% |
| Operating Income | $170.4M 15.6% | $146.2M 15.9% | $119.1M 13.9% | — | — | — | — | — | — | — |
| Interest Expense | $17.5M 1.6% | $15.2M 1.7% | $8.8M 1.0% | $4.9M 0.6% | $2.2M 0.3% | $6.7M 0.9% | $8.1M 1.1% | — | — | — |
| Pretax Income | $152.9M 14.0% | $131.0M 14.2% | $110.4M 12.9% | $106.4M 12.4% | $80.7M 11.3% | $36.4M 5.0% | $97.9M 13.5% | $81.1M 10.5% | $80.2M 11.7% | $68.4M 12.0% |
| Income Tax Expense | $36.6M 3.3% | $28.3M 3.1% | $24.7M 2.9% | $24.1M 2.8% | $17.2M 2.4% | $13.5M 1.8% | $20.4M 2.8% | -$5.2M -0.7% | $26.4M 3.9% | $22.5M 3.9% |
| Net Income | $299.2M 27.3% | $101.9M 11.1% | $92.5M 10.8% | $82.3M 9.6% | $63.5M 8.9% | $99.4M 13.6% | $81.0M 11.2% | $92.1M 11.9% | $53.7M 7.8% | $45.9M 8.0% |
| Per Share | ||||||||||
| EPS (Basic) | $11.59 | $3.95 | $3.59 | $3.17 | $2.44 | $3.82 | $3.12 | $3.56 | $2.08 | $1.78 |
| EPS (Diluted) | $11.55 | $3.94 | $3.58 | $3.16 | $2.42 | $3.81 | $3.10 | $3.54 | $2.07 | $1.77 |
| Weighted Avg Shares (Basic) | 25.8M | 25.8M | 25.8M | 25.9M | 26.0M | 26.0M | 25.9M | 25.9M | 25.8M | 25.8M |
| Weighted Avg Shares (Diluted) | 25.9M | 25.9M | 25.9M | 26.1M | 26.2M | 26.1M | 26.1M | 26.1M | 26.0M | 26.0M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Solve the discounted cash flow backwards, then stress-test the assumptions.
Average free cash flow across the last 3 positive fiscal years (FY2023, FY2024, FY2025). Smooths the cycle. Stock compensation is NOT charged — it is added back inside operating cash flow.
To be worth $231.50 today, the market must believe free cash flow compounds 17.7%/yr for a decade (off $120.7M on the 3-yr avg basis).
On the basis ($111.3M) the requirement is 18.7%/yr. Shares issued to employees are added back in operating cash flow, so this basis treats them as free.
The market's 17.7% is more optimistic than its 9-yr track record.
Default is 8.9% — this company's computed cost of capital (computed WACC), the same rate the Analysis tab discounts at.
2-stage DCF · 0.03B shares (market data) · net debt $84.7M
mean 30.1% · volatility σ 65% · implied rate exceeded in 4/9 yrs
Central path = implied 17.7%/yr growth; shaded band = ±1σ (65%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Interest is easily covered by operating profit. Effective rate ~9.4% on $186.0M of debt.
Cash of $101.3M fully covers short-term debt of $20.0M.
Mostly long-term debt (balance-sheet current vs non-current split). A year-by-year maturity schedule wasn't disclosed for this issuer.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Educational — not a recommendation.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
EOD close · as of 2026-11-13
Where each multiple sits in its own 14-yr range · 81th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 14-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
ROE 19% against ROIC 17% — 2% of the return on equity comes from leverage and buybacks rather than from the operating business.
Equity is the year-end figure. On average equity over the two year-ends, ROE is 21.5% — the two diverge when buybacks or issuance move equity during the year.
What the company owes vs. what it holds
This shows debt/cash structure and net leverage. The year-by-year maturity schedule is on the Debt & Leverage tab.
Latest year: profit growth vs revenue growth
Low operating leverage — profit tracks sales closely (stable, less cyclical).
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 54.4 | 60.3 | 62.7 | 62.2 | 61.3 | 58.7 | 57.7 | 57.9 |
| R&D | 1.4 | 1.7 | 1.8 | 2.2 | 1.4 | 1.5 | 1.3 | 2.1 |
| SG&A | 19.8 | 22.4 | 21.8 | 23.4 | 22.8 | 23.8 | 22.7 | 21.4 |
| Operating Income | — | — | — | — | — | 13.9 | 15.9 | 15.6 |
| Income Tax | -0.7 | 2.8 | 1.8 | 2.4 | 2.8 | 2.9 | 3.1 | 3.3 |
| Net Income | 11.9 | 11.2 | 13.6 | 8.9 | 9.6 | 10.8 | 11.1 | 27.3 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on ESE: price, valuation and headline fundamentals from SEC filings. The four questions at the top of the page are where the judgements live.
Earns -1.34pts against its cost of capital — capital is being consumed, not created.
| Period | ROIC | Cost of capital | Spread |
|---|---|---|---|
| FY2023 | 7.3% | 9.2% | -1.9pts |
| FY2024 | 8.3% | 8.9% | -0.7pts |
| FY2025 | 7.7% | 8.9% | -1.2pts |
| Now | 17.3% | 8.9% | 8.4pts |
| Fiscal year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY2016 | 38.6% | not reported | 8.0% |
| FY2017 | 36.3% | not reported | 7.8% |
| FY2018 | 45.6% | not reported | 11.9% |
| FY2019 | 39.7% | not reported | 11.2% |
| FY2020 | 37.3% | not reported | 13.6% |
| FY2021 | 37.8% | not reported | 8.9% |
| FY2022 | 38.7% | not reported | 9.6% |
| FY2023 | 41.3% | 13.9% | 10.8% |
| FY2024 | 42.3% | 15.9% | 11.1% |
| FY2025 | 42.1% | 15.6% | 27.3% |
Leverage and buybacks account for 2 points of the 19% return on equity in FY2025. The business earns 17% on the capital it employs; the rest is balance sheet.
ROE is on average equity; ROIC is NOPAT over average invested capital (debt plus equity less excess cash). The gap is not a single adjustment.
$760M of goodwill — 44% of invested capital. The gap is what was paid above the fair value of what was bought; it is real capital shareholders provided, so neither bar is the whole answer.
ROIC ex-goodwill is 13.43% against 7.57% reported — the return is earned on a capital base inflated by what was paid for acquisitions, not by the operating business alone.
Accruals are positive and DSO is up +14 days over 3 years — profit is being recognised ahead of collection.
Accruals are positive and DSO is up +14 days over 3 years. Either alone is explainable; together they are revenue recognised ahead of collection.
Covers interest 6.8x even after a 30% EBITDA decline.
| EBITDA decline | Interest coverage |
|---|---|
| 0% | 9.73x |
| 5% | 9.25x |
| 10% | 8.76x |
| 15% | 8.27x |
| 20% | 7.79x |
| 25% | 7.30x |
| 30% | 6.81x |
| 35% | 6.33x |
| 40% | 5.84x |
| 45% | 5.35x |
| 50% | 4.87x |
| 55% | 4.38x |
| 60% | 3.89x |
Balance sheet at 2025-09-30. Undrawn revolving credit is not shown: the tag is collected but not yet mapped through to the API.
The maturity schedule is not part of this verdict — its filing anchor is often older than the balance sheet it sits beside, so a wall inside 24 months may not be visible here.
At $231.50, free cash flow must compound 17.8%/yr for 10 years. It has done 16.82%/yr over 6 years.
| Fiscal year | FCF growth | Price requires |
|---|---|---|
| FY2020 | −38.0% | 17.8% |
| FY2021 | 92.2% | 17.8% |
| FY2022 | 7.0% | 17.8% |
| FY2023 | −44.5% | 17.8% |
| FY2024 | 73.4% | 17.8% |
| FY2025 | 107.1% | 17.8% |
The percentile ranks the FISCAL-YEAR point, because the distribution behind each strip is built from fiscal-year closes — ranking a TTM figure inside it would compare two different bases. TTM basis: TTM (share count from the last fiscal year — the TTM window reports none).
The implied rate has been matched or beaten in 3 of the last 6 years.
| Step | Amount | Running total |
|---|---|---|
| Net income | $299M | $299M |
| Share-based comp | $11M | $310M |
| Other non-cash & working capital | −$68M | $242M |
| Operating cash flow | $242M | $242M |
| Capex | −$36M | $206M |
| Free cash flow | $206M | $206M |
| FCF after SBC | $195M | $195M |
| Fiscal year | Revenue growth | Receivables growth | Gap |
|---|---|---|---|
| FY2020 | 0.6% | -9.2% | -9.8 points |
| FY2021 | -2.1% | 1.5% | 3.6 points |
| FY2022 | 19.9% | 12.5% | -7.3 points |
| FY2023 | -0.2% | 15.0% | 15.2 points |
| FY2024 | 7.4% | 17.3% | 9.9 points |
| FY2025 | 19.2% | 14.2% | -5.0 points |
| Fiscal year | DSO | DIO | DPO | Cash conversion cycle |
|---|---|---|---|---|
| FY2019 | 79.8 days | 104.1 days | 53.2 days | 130.8 days |
| FY2020 | 72 days | 107.8 days | 40.2 days | 139.5 days |
| FY2021 | 74.6 days | 120.7 days | 46.5 days | 148.8 days |
| FY2022 | 70.1 days | 112.8 days | 54.7 days | 128.2 days |
| FY2023 | 80.7 days | 133.7 days | 63.2 days | 151.2 days |
| FY2024 | 88.2 days | 134.5 days | 61.2 days | 161.5 days |
| FY2025 | 84.5 days | 125.3 days | 55.5 days | 154.3 days |
| Fiscal year | Accruals / assets |
|---|---|
| FY2019 | -1.6 percent |
| FY2020 | 1.3 percent |
| FY2021 | -3.8 percent |
| FY2022 | -3.2 percent |
| FY2023 | 0.9 percent |
| FY2024 | -1.4 percent |
| FY2025 | 2.4 percent |
Below the line, the asset base is being consumed faster than it is replaced.
Below the line for 7 consecutive years to the latest.
Depreciation here includes amortisation of acquired intangibles — goodwill written down over time, customer lists, acquired technology. Capex does not replace those and is not meant to, so an acquisitive or asset-light company sits below 1.0 permanently and correctly. The signal is cleanest for capital-intensive businesses, where the two measure the same physical base. For that reason this informs the earnings-quality verdict but never caps it.
Last reported position per insider, carried forward. Steps can be a holding disclosed for the first time rather than a trade.
| Date | Insider | What it was |
|---|
SBC is added back inside operating cash flow, so reported free cash flow treats shares issued to employees as free. Percent of revenue says how expensive the payroll is; percent of operating cash flow says how much of the cash exists only because the charge was added back. The buyback offset is buybacks over SBC — below 1.0 the repurchase does not cover the shares issued.
Figures are the latest fiscal year (FY2025) from the company's own filings, not a trailing-twelve-month window — Q2 reads fiscal years throughout so the cash-conversion ratios and these share one basis. A blank is a line the filer did not report; it is never read as zero.
| Shares |
|---|
| Price |
|---|
| Value |
|---|
| 2026-11-02 | 2 co-filers Group filing | Option exercise | 197 | $237.70 | $47k |
| 2026-11-02 | 2 co-filers Group filing | Option exercise | 197 | $237.70 | — |
| 2026-10-21 | Abson Jeremy Director | Grant | 167 | $269.92 | — |
| 2026-10-15 | Campbell David A Director | Grant | 1 | $252.67 | — |
| 2026-10-15 | Valdez Gloria L Director | Grant | 3 | $252.67 | — |
| 2026-10-15 | Khilnani Vinod M Director | Grant | 0 | $252.67 | — |
| 2026-10-15 | Conner Penelope M Director | Grant | 0 | $252.67 | — |
| 2026-10-15 | Dewar Patrick M Director | Grant | 8 | $252.67 | — |
| 2026-10-15 | Hess Janice L. Director | Grant | 0 | $252.67 | — |
| 2026-10-15 | Phillippy Robert J Director | Grant | 6 | $252.67 | — |
| 2026-07-17 | Khilnani Vinod M Director | Grant | 0 | $318.52 | — |
| 2026-07-17 | Hess Janice L. Director | Grant | 0 | $318.52 | — |
| 2026-07-17 | Valdez Gloria L Director | Grant | 2 | $318.52 | — |
| 2026-07-17 | Conner Penelope M Director | Grant | 0 | $318.52 | — |
| 2026-07-17 | Campbell David A Director | Grant | 1 | $318.52 | — |
| 2026-07-17 | Phillippy Robert J Director | Grant | 5 | $318.52 | — |
| 2026-07-17 | Dewar Patrick M Director | Grant | 6 | $318.52 | — |
| 2026-05-01 | 3 co-filers Group filing | Option exercise | 197 | $326.96 | $64k |
| 2026-05-01 | 3 co-filers Group filing | Option exercise | 197 | $326.96 | — |
| 2026-05-01 | 3 co-filers Group filing | Other | 106 | $326.96 | — |
| 2026-04-17 | Dewar Patrick M Director | Grant | 6 | $314.92 | — |
| 2026-04-17 | Khilnani Vinod M Director | Grant | 0 | $314.92 | — |
| 2026-04-17 | Conner Penelope M Director | Grant | 0 | $314.92 | — |
| 2026-04-17 | Phillippy Robert J Director | Grant | 5 | $314.92 | — |
| 2026-04-17 | Valdez Gloria L Director | Grant | 2 | $314.92 | — |
| 2026-04-17 | Campbell David A Director | Grant | 1 | $314.92 | — |
| 2026-04-17 | Hess Janice L. Director | Grant | 0 | $314.92 | — |
| 2026-02-05 | 3 co-filers Group filing | Option exercise | 1,349 | $238.40 | $322k |
| 2026-02-05 | 3 co-filers Group filing | Option exercise | 1,349 | $238.40 | $322k |
| 2026-02-05 | 3 co-filers Group filing | Option exercise | 1,349 | $238.40 | $322k |
| 2026-02-05 | 3 co-filers Group filing | Option exercise | 1,349 | $238.40 | $322k |
| 2026-02-05 | 3 co-filers Group filing | Option exercise | 1,349 | $238.40 | $322k |
| 2026-02-05 | 3 co-filers Group filing | Option exercise | 1,349 | $238.40 | — |
| 2026-02-05 | 3 co-filers Group filing | Option exercise | 1,349 | $238.40 | — |
| 2026-02-05 | 3 co-filers Group filing | Option exercise | 1,349 | $238.40 | — |
| 2026-02-05 | 3 co-filers Group filing | Option exercise | 1,349 | $238.40 | — |
| 2026-02-05 | 3 co-filers Group filing | Option exercise | 1,349 | $238.40 | — |
| 2026-02-05 | 3 co-filers Group filing | Other | 0 | $238.40 | — |
| 2026-02-05 | 3 co-filers Group filing | Other | 0 | $238.40 | — |
| 2026-02-05 | 3 co-filers Group filing | Other | 0 | $238.40 | — |
Every row is classified by what it MEANT, not by its SEC code. A code is not a meaning: code P (“purchase”) also covers dividend reinvestment and employee stock purchase plans, and code S (“sale”) also covers 10b5-1 plan sales scheduled months earlier and option exercises sold the same day.
Across 30 days of all filings, $5.08bn of insider selling contained $3.50bn of plan sales and $0.46bn of exercise-and-sell. Only 29% was discretionary. Reading an unclassified feed badly overstates how much insiders decided.
Buys and sales are counted separately and never netted. They are different decisions by different people; a company where one officer bought while another sold is not “neutral”.
The holding line carries each insider's last reported position forward, so it shows the total held rather than a sawtooth of whoever traded that day. It covers only insiders who filed in the window.
“Filed late” counts calendar days past the two-business-day deadline with five days' grace, so a Thursday or Friday trade crossing a weekend is never flagged. It describes the company's filing discipline, not the trade.
Insider activity is descriptive. Nothing here is investment advice.